Zhaoke Ophthalmology (06622) Releases January 2026 Monthly Return

Bulletin Express
02/03

Zhaoke Ophthalmology Limited (06622) issued its monthly return for the period ended January 31, 2026. The report shows that the company's authorized share capital remained unchanged at USD 400,000, with 1,600,000,000,000 ordinary shares at a par value of USD 0.00000025 per share.

According to the filing, the total number of issued shares stayed at 547,970,012, with no treasury shares reported. The data also confirms compliance with the applicable public float requirement. Details in the share option schemes indicate that no new shares were issued through option exercises during the month. No other movements in issued shares, treasury shares, warrants, or convertible securities were disclosed.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10